Symbols

NVAC(Delisted)

NorthView·NASDAQ

--(--)

Signals Analysis

Bullish signal 1

Bearish signal 0

Bullish Abandoned Baby

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About NVAC

Profusa, Inc.

Industry

Established Date

04/19/2021

Listing Date

01/24/2022

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

Security Type

Common stock

Office address

207 West 25th St, 9th Floor, New York, NY 10001

Business

Introduction

Profusa, Inc., was incorporated as a Delaware corporation on April 19, 2021. Profusa, Inc., a digital health-based technology company, has developed a real-time, consumer-friendly platform designed to measure the biochemistry of individuals, is easy to use, cost-effective, and provides the necessary data to manage chronic disease and health and wellness decisions to improve health outcomes for a large number of potential users.

Company Financials

EPS

NVAC has released its 2025 Q3 earnings. EPS was reported at -0.7, versus the expected 0, missing expectations. The chart below visualizes how NVAC has performed over recent quarters, highlighting trends in earnings surprises.